Fortrea logo

Fortrea

FTRE | NASDAQ
Chart Builder DCF Calculator
$19.79
-$0.41 (-2.03%)
At close: Nov 16, 2026, 4:00 PM ET
$19.79
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.03%

Rating

Updated: Nov 16, 2026
26.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #889/1021 (Top 87%)

Key Statistics

Market Data

Market Cap $1.87B
1D Range
19.16 20.20
52W Range
8.87 25.88

Valuation (TTM)

PE -26.39
PB 3.52
EV/EBITDA 26.56

Valuation (NTM)

Forward PE 23.76
Forward PEG -0.40
Price Target $23.50
Loading financial charts...

Profile

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's oper...

Sector Healthcare
Industry Biotechnology
Employees 14,000
IPO Date Jun 20, 2023
Fiscal Year January - December

Latest News

Fortrea: A Promising Turnaround At An Attractive Valuation

3 days ago · seekingalpha.com

Fortrea: A Promising Turnaround At An Attractive Valuation
What Fortrea (FTRE) Said on Its Q3 Earnings Call

19 days ago · marketbeat.com

What Fortrea (FTRE) Said on Its Q3 Earnings Call
Fortrea Holdings Inc. (FTRE) Q3 2026 Earnings Call Transcript

19 days ago · seekingalpha.com

Fortrea Holdings Inc. (FTRE) Q3 2026 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Q3 Earnings and Revenues Surpass Estimates

19 days ago · zacks.com

Fortrea Holdings Inc. (FTRE) Q3 Earnings and Revenues Surpass Estimates
Fortrea Reports Third Quarter 2026 Results

19 days ago · globenewswire.com

Fortrea Reports Third Quarter 2026 Results
Fortrea to Participate in Jefferies Global Healthcare Conference

21 days ago · globenewswire.com

Fortrea to Participate in Jefferies Global Healthcare Conference
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

25 days ago · globenewswire.com

Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
Fortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy?

26 days ago · zacks.com

Fortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy?
Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials

28 days ago · globenewswire.com

Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
3 Top Small-Cap Stocks With Market-Beating Momentum

1 month ago · seekingalpha.com

3 Top Small-Cap Stocks With Market-Beating Momentum

Earnings

Latest Earnings
Oct 29, 2026
EPS
$0.28
Beat +28.91%
REV
$691.5M
Beat +2.97%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
9
Consensus
Buy
Price Target
$23.50
Upside
+18.75%
Buy (7)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.